Image: CerTest Biotec has opened a new facility in Spain for R&D and manufacture of molecular diagnostics products (Photo courtesy of CerTest Biotec).
CerTest Biotec (Zaragoza, Spain), a biotechnology company focused on the development and manufacturing of IVD diagnostic products, has opened a new facility in Spain for the research, development and manufacture of molecular diagnostics products.
CerTest develops, manufactures and sells a wide range of products for the identification of the agents causing infectious diseases in health facilities, laboratories and hospitals. The company develops and provides clinical diagnostics products with high standards of quality, sensitivity, specificity and reproducibility, allowing the identification of pathogens at early stages of infection. It also collaborates with a large number of hospitals and research institutes in Spain and abroad.
The new facility, with a surface area of 4,500 square meters, comprises state-of-the-art laboratories, offices, warehouse and production and quality control areas, among others and has been set up at an investment of 5 million Euros. With this facility, CerTest Biotec will now have a total floor space of 7,000 square meters and will continue to expand in the field of molecular biology, which is one of the company’s specialties.